KEGG analysis enriched the top 20 most crucial pathways, and the results suggested that SG-D may exert anti-gastric carcinoma effects through pathways in cancer, MAPK signaling pathway and PI3K/Akt signaling pathway (Figure 3B). Here, AKT1 is linked to gastric carcinoma.